State Board of Pharmacy: News


Rulemaking Hearing - July 19

The Colorado State Board of Pharmacy will hold a public rulemaking hearing on Thursday, July 19, 2018 regarding proposed Rules under consideration. Please download the official hearing notice for the list of proposed Rule changes. 

Meeting Details

Oral and Written Comments

Interested parties will have an opportunity to make brief oral presentations at the rulemaking hearing, unless the Board determines such presentations are unnecessary. Written comments may be submitted regarding any of the listed rulemaking matters no later than June 29, 2018. All submissions will be considered. The rules under consideration may be changed or modified after public comment and hearing.


Stakeholder Meeting - June 11

The Colorado State Board of Pharmacy is considering amending Board Rules 3.05.00, 6.00.00, 14.00.40, 14.00.80, 17.00.00 and 25.00.14 to improve the administration and enforcement of the Pharmacists, Pharmacy Businesses and Pharmaceuticals Act.

Colorado law permits agencies to informally solicit views from interested stakeholders concerning proposed draft rules before commencing the formal rulemaking process. We invite you to share your thoughts and recommendations as we improve a preliminary draft of proposed rules to regulate the practice of pharmacy in Colorado. 

Draft Rules and Meeting Materials

  • Download the official stakeholder notice.
  • Download the draft rules for the meeting:
    • Rule 3.05.00 - The purpose of the proposed addition of Board Rule 3.05.00 is to specify the requirements for pharmacists when prescribing over-the-counter medications. 
    • Rule 6.00.00 - The purpose of any proposed amendments to Board Rule 6.00.00 is to address the requirements of drug therapy management. 
    • Rule 14.00.40 and 14.00.80 - The purpose of the proposed amendments to Board Rules 14.00.40 and 14.00.80 is to allow, and to address the corresponding consultant pharmacist expectations as to visitation frequency, a telepharmacy to dispense up to 50,000 dispensing units in a calendar year. 
    • Rule 17.00.00 - The purpose of the proposed amendments to Board Rule 17.00.00 is to address the education requirements to participate in statewide protocols as part of collaborative pharmacy. 
    • Rule 17.00.00 Appendix A
    • Rule 17.00.00 Appendix B
    • Rule 25.00.14 - The purpose of the proposed amendment to Board Rule 25.00.14 is to allow, and to address the corresponding expectations of involved pharmacists, the packaging and labeling of medication for a specific patient by an automated device at a specialized prescription drug outlet. 

Meeting Information

  • Monday, June 11, 2018 at 8:30 a.m. (MDT)

Three Ways to Participate

  1. In Person: Civic Center Plaza, 1560 Broadway, Conference Room 110D, Denver, CO 80202
  2. By Webinar: Register at https://attendee.gotowebinar.com/register/4125068951236793858.
  3. By Written Comment: Provide written comments in advance or after the meeting to dora_pharmacyboard@state.co.us no later than June 8, 2018, at 5 p.m. (MDT)

Meeting Format

Attendees may provide comments, concerns, and proposals to the program in writing or in person at the meeting. Participants will be able to discuss topics brought forward during the meeting. Program staff will moderate the discussion to ensure there is an equitable opportunity for all stakeholders to actively participate, and to ensure comments and suggested changes are collected for Board consideration and future rulemaking. This meeting is not a formal rulemaking hearing.


New Law Affects Colorado Prescribers, Limits Opioid Prescriptions

On Monday, May 21, 2018, Governor John Hickenlooper signed Senate Bill 18-22 Clinical Practice for Opioid Prescribing. The bill went into effect immediately upon the Governor’s signature. This new state law limits the number of opioid pills a healthcare provider can prescribe and affects physicians, physician assistants, advanced practice registered nurses with prescriptive authority, dentists, optometrists, podiatrists, and veterinarians.

Under the new law, a prescriber must limit a patient’s initial prescription of an opioid to a seven-day supply, if the prescriber has not written an opioid prescription for the patient in the last 12 months. The prescriber may exercise discretion in including a second fill for a seven-day supply. These limits do not apply, if, in the judgment of the prescriber, the patient:

  • Has chronic pain that typically lasts longer than 90 days or past the time of normal healing, as determined by the prescriber, or following transfer of care from another prescriber who prescribed an opioid to the patient;
  • Has been diagnosed with cancer and is experiencing cancer related pain; or
  • Is experiencing post-surgical pain, that, because of the nature of the procedure, is expected to last more than 14 days.

After the first prescription, the prescriber is required to check the Prescription Drug Monitoring Program (PDMP) database before prescribing any additional opioids for the same patient. Failure to check the PDMP constitutes unprofessional conduct if the prescriber repeatedly fails to comply with this new requirement. The second fill requirement to check the PDMP does not apply when a patient:

  • Is receiving the opioid in a hospital, skilled nursing facility, residential facility, or correctional facility;
  • Has been diagnosed with cancer and is experiencing cancer related pain; or
  • Is undergoing palliative care or hospice care;
  • Is experiencing post-surgical pain, that, because of the nature of the procedure, is expected to last more than 14 days;
  • Is receiving treatment during a natural disaster or during an incident where mass casualties have taken place; or has received only a single dose to relieve pain for a single test or procedure.

After the second opioid prescription, the law has no further restrictions on the healthcare provider’s prescribing practices. The new law does require a healthcare provider, or the provider’s designee, to specify the provider’s specialty upon the initial query of the PDMP.  It also states a violation of the new requirements does not constitute negligence or contributory negligence per se and does not create a private right of action or serve as the basis of a cause of action.


Revised Opioid Guidelines

On March 16, 2018, the revised Guidelines for Prescribing and Dispensing Opioids were adopted by all six of Colorado’s prescribing and dispensing Boards: the Colorado Dental Board, the Colorado Medical Board, the State Board of Nursing, the State Board of Optometry, the Colorado Podiatry Board, and the State Board of Pharmacy, and endorsed by the State Board of Veterinary Medicine.

This revised Policy is a product of the collaboration between the seven Boards and a robust stakeholder engagement process. Stakeholder views, opinions and comments were essential in the revision of the 2014 Policy for Prescribing and Dispensing Opioids.

Visit the Opioid Guidelines webpage.


New PDMP Delegate Training Video

A new training video is now available to show prescribers and pharmacists how to set up delegate accounts for the PDMP.  Any prescriber or pharmacist can create up to three delegate accounts for trained individuals who can check the PDMP on the prescriber or pharmacist's behalf.  You can utilize the PDMP more frequently to get the most complete medical history possible.

View the video now or access it via the "New Delegate Training Video!" button on the PDMP homepage.


Mandatory Reporting Reminder

Did you know you are a mandatory reporter? Under Colorado law, more than 40 professions are required to report suspected child abuse and elder abuse. These professions include many regulated through the Division of Professions and Occupations (DPO) at DORA, such as:

  • Physicians (including physician assistants and physicians in training);
  • Podiatrists;
  • Dentists and dental hygienists;
  • Chiropractors;
  • Nurses (including registered nurses, licensed practical nurses, and nurse practitioners);
  • Nursing home administrators;
  • Occupational therapists;
  • Optometrists;
  • Physical therapists;
  • Pharmacists;
  • Veterinarians;
  • Mental health professionals (including psychologists, social workers, professional counselors, marriage and family therapists, registered psychotherapists and all candidates for licensure);

Online trainings help mandatory reporters recognize and report abuse, neglect and exploitation. Licensees of the regulatory boards at DPO may accrue credit towards continuing education and continuing competency requirements for completing the trainings (should they exist for their profession).  

Section 19-3-304, C.R.S. outlines the persons required by law to report child abuse and/or neglect. To assist mandatory reporters, a training is available on the Colorado Department of Human Services website at http://coloradocwts.com/mandated-reporter-training.

Section 18-6.5-108, C.R.S outlines the persons required by law to report abuse and exploitation of at-risk elders and at-risk adults with intellectual and developmental disabilities. Further information and an online training can be found on the Colorado Department of Human Services website at http://www.coloradoaps.com/about-mandatory-reporting-update.html.  

If you have further questions regarding these requirements, please contact the Colorado Department of Human Services.

For questions regarding mandatory child abuse reporting, please contact the Office of Children, Youth, and Families’ Child Welfare Training System at 800-390-9619 or support@coloradocwts.com.

For questions regarding mandatory reporting of at-risk elders and at-risk adults with intellectual and developmental disabilities, please contact the Office of Community Access and Independence’s Division of Aging and Adult Services at cdhs_aps_questions@state.co.us.


Important PDMP Updates

As we work together to tackle prescription drug misuse, abuse and diversion, we see PDMP utilization rates continue to increase as the database continues to serve as an important tool for meeting the standard of care for safe prescribing.

New Website

We are pleased to announce a new and improved PDMP website: colorado.gov/dora-pdmp. We listened to your challenges and ideas and hope you’ll find the new website easier to navigate and more relevant to your needs. You will be able to link to your PDMP account and access other information directly from the homepage. We also selected a new vendor, APPRISS, and will be utilizing the PMP AWARxE system. The database interface will look different and make PDMP queries easier and quicker. We encourage your continued feedback for ongoing improvement efforts.

New State Law Improves Access to PDMP

To make the PDMP more accessible and easier for health professionals to incorporate into daily use, the Colorado General Assembly passed legislation in 2017. On April 6, 2017, Governor John Hickenlooper signed Senate Bill 17-146 Access To Prescription Drug Monitoring Program, which clarifies health professionals' access to the PDMP database by:

  • Allowing a health care provider with prescribing authority to query the PDMP about a current patient, including checking on drug interactions and side effects, thus making the PDMP an even more useful tool for health professionals in their clinical decision-making for patients;
  • Allowing a veterinarian with prescribing authority to query the PDMP about a current client if the veterinarian has a reasonable basis to suspect the client has committed drug abuse or has mistreated an animal; and
  • Allowing a pharmacist to query the PDMP about a current patient for whom the pharmacist is dispensing any prescription drug, rather than only patients receiving controlled substances.

The law became effective immediately, and the Division is working with the appropriate Boards to implement the new law including rulemaking, outreach and education. If you have questions about the Colorado PDMP, please contact Division staff at 303-894-5957 or pdmpinqr@state.co.us. If you need technical assistance with the PMP AWARxE system, please contact the vendor help desk at 1-855-263-6403.


Colorado End-of-Life Options Act

In 2016, Colorado voters approved Proposition 106, “Access to Medical Aid In Dying,” which amends Colorado statutes to include the Colorado End-of-life Options Act at Article 48 of Title 25, C.R.S. This Act requires licensed physicians or pharmacists prescribing or dispensing aid-in-dying medication to provide the Colorado Department of Public Health and Environment (CDPHE) with certain information as outlined in the respective forms below.

Rules 6 CCR 1009-4 have been adopted by the Board of Health within CDPHE describing these reporting requirements.

The Division of Professions and Occupations (Division) advises any licensed physician or pharmacist who participates in this practice to comply with all applicable provisions of the Act and corresponding rules implemented by CDPHE. The Division further recommends that you seek the advice of your employer, insurance carrier and private counsel for matters related to this law.

Additionally, the Medical Board has provided guidance to physicians in Policy 40-6.


Free Access to PainNET System for Colorado Providers

The Colorado Department of Health Care Policy and Financing (HCPF) has worked with the vendor of its Project ECHO Pain Management Program, Community Health Center, to expand access to the program website known as PainNET.

The PainNet website is an online learning community that aims to improve pain care expertise among primary care providers. The website is also now available to other Health First Colorado (Colorado’s Medicaid Program) primary care medical providers (PCMPs) for free.

The PainNET learning community enables PCMPs to develop expertise to treat patients with complex chronic pain through a combination of archived Project ECHO Pain case presentations, resource libraries, community forums and expert consultations. Providers and specialists are able to communicate through discussion boards, chat rooms and direct messaging.

This is a great resource for Colorado providers to access resources that can increase their knowledge on how to manage chronic pain more effectively.

Learn More About PainNET


Shorter Application Process for Pharmacist Grads

We want to make sure all Pharmacy Interns know about some exciting changes in our application process for aspiring pharmacists. These changes streamline the process and allow new grads to enter the workforce more quickly.

Beginning May 1, 2016, applicants for a pharmacist license in Colorado will apply directly to the National Association of Boards of Pharmacy (NABP) to take the NAPLEX and MPJE (Colorado) exams without first needing to apply for a Colorado pharmacist license. The new process  allows graduates to schedule and take the licensing exams without waiting on prior approval from DPO.  NABP will now evaluate your eligibility for the exams and determine the documentation needed to prove you have graduated from an approved school of pharmacy. To have NABP determine your eligibility, complete the NAPLEX/MPJE Eligibility Request Form and submit to NABP with the one-time $85 processing fee. NABP will also be evaluating any requests for testing accommodations. To make an accommodation request, complete and submit to NABP the Accommodation Request Form. For more information about NABP's process, see the NAPLEX - MPJE Registration Bulletin.

Additionally, a new online application provides a more user-friendly and intuitive pathway, replacing the cumbersome paper applications. Once you have passed the NAPLEX and MPJE (Colorado) and completed your 1500 experiential intern hours, you may apply for your Colorado pharmacist license. To apply, complete the PHA - Original License Score Transfer application and submit with the required fee.

We look forward to helping you join Colorado’s healthcare workforce. If you have questions, please contact us at dora_pharmacyboard@state.co.us.


Naloxone Standing Orders

In April 2015, Colorado passed a new law, Senate Bill 15-053, expanding access to the life-saving drug naloxone, which is used to reverse overdoses to narcotic drugs, such as certain prescription medications and heroin. As a result of the new law, a physician — or any medical professional with prescriptive authority — can write a standing order for naloxone that can be dispensed by other designed individuals (such as pharmacists and harm reduction organizations). 

With these standing orders, pharmacists and harm reduction organizations can now provide naloxone to those who might benefit from it the most, including:

  • A family member, friend or other person in a position to assist a person at risk of overdose
  • An employee or volunteer of a harm reduction organization
  • A first responder
  • An individual at risk of overdose

View more information and access resources for Naloxone Standing Orders.